May 9, 2018
Generic medicines have saved Americans $1.67 trillion in the last decade. Biosimilars, which are more affordable, highly similar, safe, and effective versions of complex biologic medicines, are poised to do the same thing — if they aren’t thwarted by delaying tactics instituted by some pharmaceutical companies.